Viridian Therapeutics Statistics
Total Valuation
VRDN has a market cap or net worth of $3.50 billion. The enterprise value is $2.79 billion.
| Market Cap | 3.50B |
| Enterprise Value | 2.79B |
Important Dates
The last earnings date was Wednesday, November 4, 2026, before market open.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VRDN has 113.56 million shares outstanding. The number of shares has increased by 28.70% in one year.
| Current Share Class | 113.56M |
| Shares Outstanding | 113.56M |
| Shares Change (YoY) | +28.70% |
| Shares Change (QoQ) | +5.00% |
| Owned by Insiders (%) | 0.08% |
| Owned by Institutions (%) | 106.45% |
| Float | 101.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 133.20 |
| Forward PS | 11.39 |
| PB Ratio | 7.26 |
| P/TBV Ratio | 7.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 106.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.46, with a Debt / Equity ratio of 0.42.
| Current Ratio | 14.46 |
| Quick Ratio | 14.06 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -19.27 |
Financial Efficiency
Return on equity (ROE) is -83.71% and return on invested capital (ROIC) is -43.29%.
| Return on Equity (ROE) | -83.71% |
| Return on Assets (ROA) | -36.48% |
| Return on Invested Capital (ROIC) | -43.29% |
| Return on Capital Employed (ROCE) | -48.89% |
| Weighted Average Cost of Capital (WACC) | 10.01% |
| Revenue Per Employee | $104,401 |
| Profits Per Employee | -$1.58M |
| Employee Count | 252 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.46% in the last 52 weeks. The beta is 1.07, so VRDN's price volatility has been similar to the market average.
| Beta (5Y) | 1.07 |
| 52-Week Price Change | +12.46% |
| 50-Day Moving Average | 22.27 |
| 200-Day Moving Average | 21.60 |
| Relative Strength Index (RSI) | 81.77 |
| Average Volume (20 Days) | 3,005,128 |
Short Selling Information
The latest short interest is 18.00 million, so 15.85% of the outstanding shares have been sold short.
| Short Interest | 18.00M |
| Short Previous Month | 17.97M |
| Short % of Shares Out | 15.85% |
| Short % of Float | 17.81% |
| Short Ratio (days to cover) | 8.44 |
Income Statement
In the last 12 months, VRDN had revenue of $26.31 million and -$397.60 million in losses. Loss per share was -$3.80.
| Revenue | 26.31M |
| Gross Profit | -283.73M |
| Operating Income | -468.66M |
| Pretax Income | -453.58M |
| Net Income | -397.60M |
| EBITDA | -467.96M |
| EBIT | -468.66M |
| Loss Per Share | -$3.80 |
Balance Sheet
The company has $955.21 million in cash and $245.50 million in debt, with a net cash position of $709.71 million or $6.25 per share.
| Cash & Cash Equivalents | 955.21M |
| Total Debt | 245.50M |
| Net Cash | 709.71M |
| Net Cash Per Share | $6.25 |
| Equity (Book Value) | 580.70M |
| Book Value Per Share | 4.25 |
| Working Capital | 943.08M |
Cash Flow
In the last 12 months, operating cash flow was -$341.51 million and capital expenditures -$1.94 million, giving a free cash flow of -$343.44 million.
| Operating Cash Flow | -341.51M |
| Capital Expenditures | -1.94M |
| Depreciation & Amortization | 701,000 |
| Net Borrowing | 224.18M |
| Free Cash Flow | -343.44M |
| FCF Per Share | -$3.02 |
Margins
| Gross Margin | n/a |
| Operating Margin | -1,781.38% |
| Pretax Margin | -1,724.06% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VRDN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -28.70% |
| Shareholder Yield | -28.70% |
| Earnings Yield | -12.33% |
| FCF Yield | -9.80% |
Analyst Forecast
The average price target for VRDN is $41.69, which is 35.09% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $41.69 |
| Price Target Difference | 35.09% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (3Y) | 111.87% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on November 13, 2020. It was a reverse split with a ratio of 1:15.
| Last Split Date | Nov 13, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
VRDN has an Altman Z-Score of 0.55 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.55 |
| Piotroski F-Score | 2 |